Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin to Reduce Preterm Birth in Low Resource Setting
NCT01800825Phase 4Completed
- Sponsor
- ChristianaCare
- Start
- Jul 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clindamycin in bacterial vaginosis (BV), preterm birth, sponsored by ChristianaCare. Started Jul 2013; status: completed.
02
Drugs
clindamycin
03
Conditions
bacterial vaginosis (BV)preterm birth
Beyond the preview
Go deeper on NCT01800825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800825.